Evidence map›Paper›PMID 29509803›Full record

ArticlePloS one2018

Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India.

Neeraj Raizada, Sunil D Khaparde, Soumya Swaminathan, Sanjay Sarin, Virender Singh Salhotra, Aakshi Kalra, Ashwani Khanna, K K Chopra, M Hanif, K R Umadevi and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Private sector engagement in tuberculosis detection: a bibliometric analysis.Journal of clinical tuberculosis and other mycobacterial diseases · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Neeraj RaizadaFoundation for Innovative New Diagnostics, New Delhi, India.
Sunil D KhapardeCentral TB Division, Government of India, New Delhi, India.
Soumya SwaminathanIndian Council of Medical Research, New Delhi, India.
Sanjay SarinFoundation for Innovative New Diagnostics, New Delhi, India.
Virender Singh SalhotraCentral TB Division, Government of India, New Delhi, India.
Aakshi KalraFoundation for Innovative New Diagnostics, New Delhi, India.ORCID 0000-0001-7402-8282
Ashwani KhannaState TB office, Government of NCT, New Delhi, India.
K K ChopraNew Delhi TB Centre, New Delhi, India.
M HanifNew Delhi TB Centre, New Delhi, India.
K R UmadeviNational Institute for research in Tuberculosis, Chennai, India.
Syed HissarNational Institute for research in Tuberculosis, Chennai, India.
Sreenivas Achuthan NairWorld Health Organization, Country Office for India, New Delhi, India.
C H Surya PrakashIntermediate Reference Laboratory, Hyderabad, India.
B K SahaIntermediate Reference Laboratory, Kolkata, India.
Raghuram RaoCentral TB Division, Government of India, New Delhi, India.
Claudia DenkingerFoundation for Innovative New Diagnostics, Geneva, Switzerland.
Catharina BoehmeFoundation for Innovative New Diagnostics, Geneva, Switzerland.
Government of India · INFIND · CHNational Institute of Research in Tuberculosis · INNew Delhi Tuberculosis Center · INIndian Council of Medical Research · INWorld Health Organization - India · IN

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundUnlike in adults, diagnosis of TB can be challenging in children, as signs and symptoms of paediatric TB can be very non-specific and similar to other common childhood chest infections, which may lead to under or delayed diagnosis of TB disease. In spite of the increasing availability of rapid high-sensitivity diagnostics in public and private sectors, majority of paediatric TB cases are empirically diagnosed, without laboratory confirmation. To address these diagnostic challenges, World Health Organization (WHO) has recommended upfront Xpert MTB/RIF (Xpert) testing for the diagnosis of TB in paediatric presumptive pulmonary and extra-pulmonary TB (EPTB) cases. However, in spite of the increasing availability of rapid high-sensitivity diagnostics, a significant gap exists in its application with Xpert being rarely used as an upfront diagnostic among patients presumed to have TB. Under an ongoing paediatric project since April 2014, which provided free-of-cost upfront Xpert testing, several low-cost outreach and education interventions were undertaken to increase the diagnostic uptake by different providers catering to the paediatric population, thereby increasing adherence to global guidance.

methodsProviders catering to paediatric population in the project cities were systematically mapped and contacted using different outreach strategies. The focus of outreach efforts was to increase provider literacy and increase their awareness of the availability of free rapid diagnostic services with the goal of changing their diagnostic approaches.

resultsFrom April 2014 to June 2016, more than 5,700 providers/facilities were mapped and 3,670 of them were approached. The number of providers/facilities engaged under the project increased more than 10-fold (43 in April, 2014 to 466 in June, 2016), with significant increase in project uptake, both from public and private sector. Overall 42,238 paediatric presumptive TB cases were enrolled in the project, across the four cities. Over the project period, quarterly diagnostic uptake and paediatric TB cases detection rates increased more than two-fold. TB detection rates were similar in patients from public and private sectors.

conclusionsOngoing efforts in scaling up new rapid diagnostics involves significant investments. These efforts need to be complemented with proactive provider engagement to ensure provider-literacy and awareness, for maximizing impact of this scale-up. The current project demonstrated the usefulness of outreach and education interventions for the effective uptake of newer diagnostics.

Indexed as

Community-Institutional RelationsChildCitiesHealth PersonnelHumansIndiaPediatricsPilot ProjectsPrivate SectorPublic SectorTuberculosis

Identifiers

PMID29509803
PMCPMC5839557
OpenAlexW2792384820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.